Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma

K M Kreusel1, N Bornfeld, A Lommatzsch

  • 1Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.

Ophthalmology
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD].

Die Ophthalmologie·2022
Same author

[Real-life experiences with Brolucizumab in recalcitrant neovascular age-related macular degeneration].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021
Same author

[Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor(VEGF) treatment of diabetic macular edema in the clinical routine : Comparison between cooperative and unicentric organization of treatment].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2019
Same author

[OCT-Angiography in diabetic maculopathy : Comparison between microaneurysms and the foveal avascular zone with flourescein angiography].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

[Goodpasture syndrome: ocular manifestation in a young man].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2017
Same author

[Visual acuity in anti-VEGF therapy for AMD : Can specific characteristics in the SD-OCT help?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2016

Ruthenium-106 brachytherapy effectively ablates peripheral retinal capillary hemangiomas. Favorable outcomes are likely for smaller tumors (≤5.0 mm) without pre-existing retinal detachment.

Area of Science:

  • Ophthalmology
  • Radiation Oncology

Background:

  • Peripheral retinal capillary hemangiomas are vascular tumors that can impair vision.
  • Treatment options for these tumors are limited, especially for larger or complex cases.

Purpose of the Study:

  • To evaluate the efficacy and safety of ruthenium-106 brachytherapy for large peripheral retinal capillary hemangiomas.
  • To identify factors predicting successful treatment outcomes.

Main Methods:

  • A retrospective case series of 25 eyes from 24 patients with peripheral capillary retinal hemangiomas.
  • Treatment involved ruthenium-106/106-rhodium plaque brachytherapy.
  • Outcomes assessed included hemangioma regression, retinal status, visual acuity, and need for further surgery.

Main Results:

Related Experiment Videos

  • Ruthenium-106 brachytherapy successfully destroyed 23 of 25 hemangiomas, with 16 eyes achieving a favorable outcome.
  • Tumor size ≤5.0 mm and absence of preoperative exudative retinal detachment were associated with favorable outcomes.
  • Unfavorable outcomes occurred in nine eyes, often due to large tumor size, pre-existing detachment, or vision loss.

Conclusions:

  • Ruthenium-106 brachytherapy is an effective treatment for solitary peripheral retinal hemangiomas.
  • Patient selection is crucial; smaller tumors without exudative detachment yield better results.
  • This modality offers a safe and effective option for select patients with retinal capillary hemangiomas.